Javier Terriente
ZeClinics is a biotech providing services to industry & academiaZeClinics (Barcelona, Spain) is a biopharmaceutical company using zebrafish for screenings of novel chemical molecules. Our business strengths rely on high technical expertise, top-notch research facilities and attractive strategic partnerships and academic collaborations.

Project at ZENITH
Publications
Publication 1: Jarque S, Ibarra J, Rubio-Brotons M, García-Fernández J, Terriente J. Multiplex Analysis Platform for Endocrine Disruption Prediction Using Zebrafish. Int J Mol Sci. 2019. Apr 8;20(7).
Publication 2: Pant DC, Dorboz I, Schlüter A, Fourcade S, Launay N, Joya J, Aguilera-Albesa S, Yoldi ME, Casasnovas C, Willis MJ, Ruiz M, Ville D, Lesca G, Siquier-Pernet K, Desguerre I, Yan H, Wang J, Burmeister M, Brady L, Tarnopolsky M, Cornet C, Rubbini D, Terriente J, James KN, Musaev D, Zaki MS, Patterson MC, Lanpher BC, Klee EW, Pinto E Vairo F, Wohler E, Sobreira NLM, Cohen JS, Maroofian R, Galehdari H, Mazaheri N, Shariati G, Colleaux L, Rodriguez D, Gleeson JG, Pujades C, Fatemi A, Boespflug-Tanguy O, Pujol A. Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy. J Clin Invest. 2019 Jan 8.
Publication 3: Cornet C, Di Donato V, Terriente J#. Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline. Front Pharmacol. 2018 Jul 3.
Contact
Email: hr@zeclinics.com
Website: https://www.zeclinics.com/